InvestorsHub Logo
Followers 2
Posts 810
Boards Moderated 0
Alias Born 10/26/2013

Re: zoomlik post# 1726

Wednesday, 05/22/2019 11:04:48 AM

Wednesday, May 22, 2019 11:04:48 AM

Post# of 2001
Remember if efficacy data is promising for the selected dose of 22mg, then birinapant has potential to find a room in oncology spaces as a partner for keytruda

This makes senior debt of say $50M
quite manageble and tlog shareholder could be valuable option on future sales of birinapant


(my $50M assumes debt and intersex of $60M in 2024 minus $10M for milestone for enrolling first patient in a P3 and no milestone from HDAC compound )